Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Exact Sciences Corp (NASDAQ:EXAS)

19.04
Delayed Data
As of Jan 13
 -0.03 / -0.16%
Today’s Change
4.67
Today|||52-Week Range
22.80
+42.51%
Year-to-Date
Why Exact Sciences' Stock Could Go Much Higher
Jan 13 / MotleyFool.com - Paid Partner Content
Better Buy: Myriad Genetics vs. Exact Sciences
Jan 09 / MotleyFool.com - Paid Partner Content
Why Ariad Pharmaceuticals, VCA, and Exact Sciences Jumped Today
Jan 09 / MotleyFool.com - Paid Partner Content
Why Exact Sciences Corp. Shot 44.7% Higher in 2016
Jan 04 / MotleyFool.com - Paid Partner Content
Why Exact Sciences Corp. Is Surging 19.3% Today
Jan 09 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close19.07
Today’s open19.22
Day’s range18.76 - 19.38
Volume3,369,080
Average volume (3 months)2,622,476
Market cap$2.1B
Dividend yield--
Data as of 01/13/2017

Growth & Valuation

Earnings growth (last year)-36.80%
Earnings growth (this year)+0.10%
Earnings growth (next 5 years)+22.50%
Revenue growth (last year)+2,093.38%
P/E ratioNM
Price/Sales21.56
Price/Book5.63

Competitors

 Today’s
change
Today’s
% change
JUNOJuno Therapeutics In...+0.33+1.68%
NKTRNektar Therapeutics+0.11+0.86%
RDUSRadius Health Inc+1.26+2.85%
ONCESpark Therapeutics I...-0.16-0.28%
Data as of 01/13/2017

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$39.4M
Annual profit (last year)-$157.8M
Net profit margin-400.14%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Kevin T. Conroy
Chief Operating Officer, Director &
Senior VP
Maneesh K. Arora
Corporate headquarters
Madison, Wisconsin

Forecasts


Search for Jobs